Analyst Consensus ?
ConsensusBuy48 ratings
Bullish3572.9%
Neutral918.8%
Bearish48.3%
DraftKings Inc. · DKNG · FY2025 Q4 · Calendar Q1 2026
DraftKings pairs record Q4 with a major Predictions push
The supplied analysis supports a constructive operating thesis for DraftKings, but with important execution conditions: strong reported momentum and early Predictions demand may support growth, while regulation, promotional intensity, cannibalization, and liquidity determine whether that growth translates into durable margins.
Reported After market closeNASDAQConsumer Cyclical
$9.60B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.36
Consensus $0.36
EPS surprise
0.0%
Reported versus consensus
Reported revenue
$1.99B
Consensus $1.99B
Revenue surprise
-0.0%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-13.5%
Event window
SPY move
+0.1%
Same window
Abnormal move
-13.6%
Stock minus SPY
Volume
3.9×
Versus trailing sessions
Subsequent drift
+14.4%
Up to 20 sessions
DKNGSPY benchmark
Ask FN2 about DKNG FY2025 Q4
Transcript, numbers and history already loaded
Why did DKNG fall 13.5% after beating EPS estimates in FY2025 Q4?What changed in DKNG's guidance and outlook in FY2025 Q4?Give me the bull and bear case for DKNG after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, DraftKings moved from preparing to launch Predictions and a Spanish-language app to reporting strong early Predictions demand, outlining market-making and Railbird plans, and highlighting first positive GAAP net income for fiscal 2025.
Guidance delta
Management maintained guidance while emphasizing disciplined investment in Predictions, state expansion, and market-making.
Key takeaways
- The supplied analysis describes record Q4 revenue and adjusted EBITDA, with growth across Sportsbook, Fantasy, iGaming, and Lottery.
- Predictions was presented as a major growth opportunity, with early demand supported by AI, market-making, and the planned Railbird integration.
- Management highlighted cash generation, share repurchases, and technology-led margin expansion.
- The main debate is whether Predictions and expansion can scale without regulatory, promotional, or liquidity pressures.
Management priorities
- Scale Predictions, including additional states and a dedicated market-making division.
- Integrate Railbird and continue using AI and proprietary technology to improve product, pricing, marketing, and margins.
- Pursue state expansion and disciplined marketing while continuing share repurchases as adjusted EBITDA grows.
Follow DKNG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$18.59Current
$15Low
$42.47Average
$105High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Oct 1, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Sep 24, 2026 |
| UBS | Buy | Buy | Maintain | Sep 18, 2026 |
| Needham | Buy | Buy | Maintain | Sep 18, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 3, 2026 |
| Macquarie | Outperform | Outperform | Maintain | Aug 11, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 11, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 10, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 7, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 20, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 10, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 9, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 1, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 14, 2026 |
| Mizuho | Outperform | Outperform | Maintain | May 12, 2026 |
| MoffettNathanson | Neutral | Buy | Downgrade | Apr 24, 2026 |
| Argus Research | Hold | Buy | Downgrade | Mar 17, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 3, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Feb 17, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 17, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Feb 13, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Feb 13, 2026 |
| Berenberg | Buy | Hold | Upgrade | Oct 9, 2025 |
| Jefferies | Buy | Buy | Maintain | Oct 6, 2025 |
| Northland Capital Markets | Underperform | Outperform | Downgrade | Oct 1, 2025 |
| JMP Securities | Market Outperform | Market Perform | Upgrade | Oct 1, 2025 |
| TD Securities | Buy | Buy | Maintain | Apr 24, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Apr 2, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 18, 2025 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jan 19, 2024 |
| Craig-Hallum | Buy | Buy | Maintain | Nov 15, 2023 |
| Roth MKM | Sell | Sell | Maintain | Aug 7, 2023 |
| Roth Capital | Sell | Sell | Maintain | May 8, 2023 |
| CFRA | Hold | Buy | Downgrade | May 5, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 7, 2022 |
| Redburn Partners | Neutral | Neutral | Maintain | Oct 12, 2022 |
| Loop Capital | Buy | Buy | Maintain | May 9, 2022 |
| CBRE | Hold | Hold | Maintain | Dec 7, 2021 |
| Rosenblatt | Buy | Buy | Maintain | Mar 10, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 10, 2021 |
| Wolfe Research | Perform | Peer Perform | Maintain | Sep 14, 2020 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 9, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Sep 8, 2020 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 1, 2020 |
Named analyst price targets
Upside is calculated against the persisted current price $18.59. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Robin Farley | $48 | $22.58 | +158.2% | Sep 18, 2026 |
| Bernstein | Ian Moore | $29 | $24.21 | +56.0% | Sep 3, 2026 |
| Wolfe Research | Analyst unavailable | $40 | $23.44 | +115.2% | Sep 2, 2026 |
| CBRE | Analyst unavailable | $27 | $25.03 | +45.2% | Aug 21, 2026 |
| Truist Financial | Barry Jonas | $29 | $24.85 | +56.0% | Aug 10, 2026 |
| Northland Securities | Analyst unavailable | $28 | $24.68 | +50.6% | Aug 10, 2026 |
| Guggenheim | Curry Baker | $33 | $24.03 | +77.5% | Aug 10, 2026 |
| Barclays | Analyst unavailable | $34 | $24.03 | +82.9% | Aug 10, 2026 |
| Bernstein | Analyst unavailable | $27 | $21.54 | +45.2% | Aug 6, 2026 |
| Stifel Nicolaus | Jeffrey Stantial | $38 | $23.85 | +104.4% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $29 | $24.94 | +56.0% | Jul 20, 2026 |
| Deutsche Bank | Analyst unavailable | $28 | $26.53 | +50.6% | Jul 9, 2026 |
| Susquehanna | Analyst unavailable | $31 | $25.26 | +66.8% | Jul 1, 2026 |
| UBS | Analyst unavailable | $49 | $25.37 | +163.6% | Jun 5, 2026 |
| New Street | Analyst unavailable | $29 | $26.38 | +56.0% | Jun 1, 2026 |
| UBS | Robin Farley | $43 | $25.25 | +131.3% | May 20, 2026 |
| Morgan Stanley | Analyst unavailable | $39 | $24.7 | +109.8% | May 14, 2026 |
| Mizuho Securities | Ben Chaiken | $45 | $24.51 | +142.1% | May 12, 2026 |
| Northland Securities | Analyst unavailable | $27 | $24.59 | +45.2% | May 11, 2026 |
| Guggenheim | Curry Baker | $35 | $25.52 | +88.3% | May 11, 2026 |
| Barclays | Analyst unavailable | $35 | $25.52 | +88.3% | May 11, 2026 |
| Wells Fargo | Analyst unavailable | $32 | $25.52 | +72.1% | May 10, 2026 |
| BTIG | Analyst unavailable | $30 | $25.22 | +61.4% | May 8, 2026 |
| Barclays | Analyst unavailable | $33 | $23.64 | +77.5% | Apr 16, 2026 |
| Bernstein | Ian Moore | $30 | $25.29 | +61.4% | Mar 5, 2026 |
| Jefferies | David Katz | $46 | $23.82 | +147.4% | Mar 3, 2026 |
| BTIG | Clark Lampen | $35 | $23.82 | +88.3% | Mar 3, 2026 |
| Wells Fargo | Analyst unavailable | $50 | $23.82 | +169.0% | Mar 3, 2026 |
| Berenberg Bank | Analyst unavailable | $26.4 | $22.26 | +42.0% | Feb 24, 2026 |
| Morgan Stanley | Analyst unavailable | $40 | $21.81 | +115.2% | Feb 24, 2026 |
| Needham | Analyst unavailable | $35 | $22.29 | +88.3% | Feb 17, 2026 |
| Truist Financial | Analyst unavailable | $33 | $21.6 | +77.5% | Feb 17, 2026 |
| Deutsche Bank | Analyst unavailable | $26 | $21.88 | +39.9% | Feb 17, 2026 |
| Northland Securities | Greg Gibas | $24 | $21.7 | +29.1% | Feb 17, 2026 |
| Macquarie | Analyst unavailable | $40 | $21.72 | +115.2% | Feb 17, 2026 |
| Susquehanna | Analyst unavailable | $33 | $21.48 | +77.5% | Feb 17, 2026 |
| Oppenheimer | Jed Kelly | $35 | $21.78 | +88.3% | Feb 17, 2026 |
| Stifel Nicolaus | Analyst unavailable | $40 | $21.42 | +115.2% | Feb 17, 2026 |
| Guggenheim | Analyst unavailable | $37 | $21.86 | +99.0% | Feb 17, 2026 |
| Mizuho Securities | Analyst unavailable | $44 | $21.76 | +136.7% | Feb 17, 2026 |
| Barclays | Analyst unavailable | $37 | $21.76 | +99.0% | Feb 17, 2026 |
| Bernstein | Analyst unavailable | $28 | $21.76 | +50.6% | Feb 16, 2026 |
| Wells Fargo | Analyst unavailable | $30 | $21.76 | +61.4% | Feb 16, 2026 |
| BTIG | Clark Lampen | $37 | $21.76 | +99.0% | Feb 16, 2026 |
| BMO Capital | Brian Pitz | $42 | $21.48 | +125.9% | Feb 13, 2026 |
| Canaccord Genuity | Analyst unavailable | $44 | $25.16 | +136.7% | Feb 13, 2026 |
| Bernstein | Analyst unavailable | $32 | $27.01 | +72.1% | Feb 6, 2026 |
| Canaccord Genuity | Michael Graham | $50 | $27.42 | +169.0% | Feb 3, 2026 |
| Redburn Partners | Analyst unavailable | $35 | $28.74 | +88.3% | Jan 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $44 | $29.94 | +136.7% | Jan 30, 2026 |
| Guggenheim | Analyst unavailable | $42 | $30.12 | +125.9% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $44 | $30.58 | +136.7% | Jan 27, 2026 |
| Morgan Stanley | Analyst unavailable | $53 | $35.46 | +185.1% | Jan 16, 2026 |
| Wells Fargo | Analyst unavailable | $49 | $34.32 | +163.6% | Jan 14, 2026 |
| Truist Financial | Analyst unavailable | $43 | $34.21 | +131.3% | Dec 22, 2025 |
| UBS | Ben Chaiken | $46 | $33.72 | +147.4% | Dec 19, 2025 |
| BMO Capital | Analyst unavailable | $63 | $30.57 | +238.9% | Nov 4, 2025 |
| Bernstein | Ian Moore | $50 | $30.59 | +169.0% | Nov 3, 2025 |
| Susquehanna | Analyst unavailable | $59 | $33.51 | +217.4% | Oct 14, 2025 |
| Northland Securities | Analyst unavailable | $30 | $33.2 | +61.4% | Oct 13, 2025 |
| Berenberg Bank | Jack Cummins | $43 | $33.98 | +131.3% | Oct 9, 2025 |
| Mizuho Securities | Analyst unavailable | $54 | $32.95 | +190.5% | Oct 7, 2025 |
| Jefferies | Analyst unavailable | $51 | $35.46 | +174.3% | Oct 6, 2025 |
| Jefferies | Analyst unavailable | $52 | $35.37 | +179.7% | Oct 6, 2025 |
| BTIG | Analyst unavailable | $45 | $35.16 | +142.1% | Oct 2, 2025 |
| Northland Securities | Greg Gibas | $33 | $37.4 | +77.5% | Oct 1, 2025 |
| JMP Securities | Analyst unavailable | $51 | $37.4 | +174.3% | Oct 1, 2025 |
| Jefferies | Analyst unavailable | $54 | $46.09 | +190.5% | Aug 21, 2025 |
| Susquehanna | Joseph Stauff | $64 | $43.3 | +244.3% | Aug 8, 2025 |
| Deutsche Bank | Steven Pizzella | $47 | $42.88 | +152.8% | Aug 8, 2025 |
| Barclays | Brandt Montour | $51 | $43.94 | +174.3% | Jul 18, 2025 |
| Bernstein | Ian Moore | $46 | $34.32 | +147.4% | Jun 3, 2025 |
| Mizuho Securities | Analyst unavailable | $59 | $33.28 | +217.4% | Apr 28, 2025 |
| Northland Securities | Analyst unavailable | $50 | $33.79 | +169.0% | Apr 25, 2025 |
| BMO Capital | Brian Pitz | $65 | $34.5 | +249.7% | Apr 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $53 | $33.47 | +185.1% | Apr 22, 2025 |
| Jefferies | David Katz | $60 | $34.22 | +222.8% | Apr 13, 2025 |
| JMP Securities | Jordan Bender | $57 | $34.43 | +206.6% | Apr 2, 2025 |
| Needham | Analyst unavailable | $65 | $50.95 | +249.7% | Feb 18, 2025 |
| Argus Research | John Staszak | $60 | $53.49 | +222.8% | Feb 18, 2025 |
| BTIG | Clark Lampen | $59 | $41.39 | +217.4% | Feb 3, 2025 |
| CBRE | John DeCree | $54 | $41.9 | +190.5% | Jan 29, 2025 |
| Deutsche Bank | Carlo Santarelli | $33 | $36.51 | +77.5% | Nov 8, 2024 |
| CFRA | Zachary Warring | $46 | $40.13 | +147.4% | Nov 8, 2024 |
| Piper Sandler | Matt Farrell | $53 | $40.13 | +185.1% | Nov 8, 2024 |
| Mizuho Securities | Jed Kelly | $62 | $37.65 | +233.5% | Oct 18, 2024 |
| BNP Paribas | Alistair Johnson | $35 | $35.9 | +88.3% | Sep 10, 2024 |
| Susquehanna | Joseph Stauff | $48 | $33.65 | +158.2% | Sep 4, 2024 |
| Craig-Hallum | Ryan Sigdahl | $57 | $36.12 | +206.6% | Aug 23, 2024 |
| Argus Research | John Staszak | $40 | $32.06 | +115.2% | Aug 15, 2024 |
| Morgan Stanley | Stephen Grambling | $47 | $29.85 | +152.8% | Aug 13, 2024 |
| Stifel Nicolaus | Jeffrey Stantial | $48 | $32.02 | +158.2% | Aug 5, 2024 |
| Truist Financial | Barry Jonas | $50 | $31.86 | +169.0% | Aug 5, 2024 |
| CFRA | Zachary Warring | $42 | $32.02 | +125.9% | Aug 2, 2024 |
| BMO Capital | Brian Pitz | $48 | $31.62 | +158.2% | Aug 2, 2024 |
| Truist Financial | Barry Jonas | $53 | $38.35 | +185.1% | Jul 18, 2024 |
| Macquarie | Chad Beynon | $52 | $38.35 | +179.7% | Jul 17, 2024 |
| Barclays | Brandt Montour | $53 | $36.74 | +185.1% | Jul 10, 2024 |
| UBS | Robin Farley | $56 | $37.9 | +201.2% | Jul 8, 2024 |
| Oppenheimer | Jed Kelly | $58 | $38.17 | +212.0% | Jul 1, 2024 |
| Susquehanna | Joseph Stauff | $49 | $35.68 | +163.6% | Jun 5, 2024 |
| Stifel Nicolaus | Jeff Stantial | $50 | $36.61 | +169.0% | May 29, 2024 |
| Morgan Stanley | Ed Young | $51 | $35.56 | +174.3% | May 28, 2024 |
| UBS | Robin Farley | $60 | $44.13 | +222.8% | May 15, 2024 |
| Deutsche Bank | Carlo Santarelli | $35 | $44.02 | +88.3% | May 6, 2024 |
| Stifel Nicolaus | Jeff Stantial | $51 | $41.79 | +174.3% | May 6, 2024 |
| BTIG | Clark Lampen | $55 | $41.79 | +195.9% | May 6, 2024 |
| Needham | Bernie McTernan | $60 | $41.79 | +222.8% | May 6, 2024 |
| Barclays | Brandt Montour | $54 | $41.79 | +190.5% | May 6, 2024 |
| Truist Financial | Barry Jonas | $55 | $41.82 | +195.9% | May 3, 2024 |
| Craig-Hallum | Ryan Sigdahl | $55 | $43.86 | +195.9% | May 3, 2024 |
| Susquehanna | Joseph Stauff | $56 | $43.22 | +201.2% | Apr 29, 2024 |
| Oppenheimer | Jed Kelly | $60 | $40.55 | +222.8% | Apr 22, 2024 |
| Goldman Sachs | Ben Miller | $60 | $43.72 | +222.8% | Apr 16, 2024 |
| Morgan Stanley | Stephen Grambling | $50 | $45.03 | +169.0% | Apr 9, 2024 |
| New Street | Shaun Kelley | $54 | $45.35 | +190.5% | Mar 28, 2024 |
| MoffettNathanson | Robert Fishman | $55 | $45.35 | +195.9% | Mar 28, 2024 |
| Needham | Bernie McTernan | $58 | $48.68 | +212.0% | Mar 27, 2024 |
| Mizuho Securities | Ben Chaiken | $58 | $48.62 | +212.0% | Mar 26, 2024 |
| Susquehanna | Joseph Stauff | $54 | $47.32 | +190.5% | Mar 25, 2024 |
| Barclays | Brandt Montour | $50 | $41.28 | +169.0% | Feb 23, 2024 |
| Truist Financial | Barry Jonas | $45 | $44.91 | +142.1% | Feb 16, 2024 |
| Stifel Nicolaus | Jeff Stantial | $45 | $37.62 | +142.1% | Jan 19, 2024 |
| BMO Capital | Brian Pitz | $43 | $34.4 | +131.3% | Jan 9, 2024 |
| Needham | Bernie McTernan | $50 | $38.68 | +169.0% | Nov 20, 2023 |
| Guggenheim | Curry Baker | $45 | $37.11 | +142.1% | Nov 16, 2023 |
| Morgan Stanley | Stephen Grambling | $36 | $26.92 | +93.7% | Oct 30, 2023 |
| Needham | Bernie McTernan | $44 | $31.38 | +136.7% | Sep 18, 2023 |
| Oppenheimer | Jed Kelly | $40 | $28.51 | +115.2% | Aug 9, 2023 |
| Roth Capital | Edward Engel | $20 | $30.95 | +7.6% | Aug 4, 2023 |
| MKM Partners | Edward Engel | $20 | $31.36 | +7.6% | Jul 18, 2023 |
| Truist Financial | Barry Jonas | $26 | $24.68 | +39.9% | Jun 20, 2023 |
| JMP Securities | Jordan Bender | $26 | $24.7 | +39.9% | May 5, 2023 |
| Needham | Bernie McTernan | $28 | $18.22 | +50.6% | Apr 10, 2023 |
| Argus Research | John Eade | $22 | $19.5 | +18.3% | Mar 7, 2023 |
| Needham | Bernie McTernan | $20.28 | $20.54 | +9.1% | Feb 21, 2023 |
| Roth Capital | Edward Engel | $15 | $16.83 | -19.3% | Feb 9, 2023 |
| Piper Sandler | Analyst unavailable | $15 | $11.48 | -19.3% | Jan 6, 2023 |
| Needham | Bernie McTernan | $20 | $11.16 | +7.6% | Dec 27, 2022 |
| JMP Securities | Jordan Bender | $23 | $14.66 | +23.7% | Nov 29, 2022 |
| Piper Sandler | Analyst unavailable | $21 | $14.9 | +13.0% | Nov 18, 2022 |
| Susquehanna | Analyst unavailable | $24 | $15.62 | +29.1% | Sep 6, 2022 |
| Truist Financial | Barry Jonas Jonas | $20 | $16.5 | +7.6% | Aug 30, 2022 |
| Barclays | Analyst unavailable | $18 | $18.44 | -3.2% | Aug 8, 2022 |
| Truist Financial | Barry Jonas | $16 | $13.73 | -13.9% | Jul 30, 2022 |
| Citigroup | Analyst unavailable | $20 | $12.37 | +7.6% | Jul 7, 2022 |
| Barclays | Brandt Montour | $14 | $12.76 | -24.7% | Jun 28, 2022 |
| National Bank | Jordan Bender | $25 | $12.76 | +34.5% | Jun 28, 2022 |
| Citigroup | Analyst unavailable | $28 | $14.72 | +50.6% | May 31, 2022 |
| Jefferies | David Katz | $33 | $12.8 | +77.5% | May 16, 2022 |
| Craig-Hallum | Ryan Sigdahl | $30 | $12.61 | +61.4% | May 15, 2022 |
| Canaccord Genuity | Michael Graham | $34 | $10.99 | +82.9% | May 10, 2022 |
| Needham | Analyst unavailable | $25 | $13.15 | +34.5% | May 9, 2022 |
| Needham | Bernie McTernan | $32 | $18.2 | +72.1% | Mar 25, 2022 |
| Roth Capital | Ed Engel | $19 | $18.59 | +2.2% | Feb 22, 2022 |
| Northland Securities | Greg Gibas | $40 | $18.59 | +115.2% | Feb 22, 2022 |
| Wells Fargo | Daniel Politzer | $19 | $18.59 | +2.2% | Feb 22, 2022 |
| Truist Financial | Barry Jonas | $22 | $18.59 | +18.3% | Feb 22, 2022 |
| Oppenheimer | Jed Kelly | $32 | $18.59 | +72.1% | Feb 22, 2022 |
| Citigroup | Jason Bazinet | $40 | $18.59 | +115.2% | Feb 22, 2022 |
| Cowen & Co. | Stephen Glagola | $60 | $22.06 | +222.8% | Feb 17, 2022 |
| Morgan Stanley | Thomas Allen | $31 | $20.33 | +66.8% | Jan 26, 2022 |
| Macquarie | Chad Beynon | $42 | $20.33 | +125.9% | Jan 26, 2022 |
| MoffettNathanson | Robert Fishman | $23 | $19.32 | +23.7% | Jan 25, 2022 |
| Northland Securities | Greg Gibas | $45 | $20.03 | +142.1% | Jan 24, 2022 |
| Truist Financial | Barry Jonas | $30 | $23.19 | +61.4% | Jan 17, 2022 |
| CBRE | John DeCree | $36 | $31.27 | +93.7% | Dec 7, 2021 |
| Benchmark Co. | Mike Hickey | $50 | $31.3 | +169.0% | Dec 2, 2021 |
| Susquehanna | Joseph Stauff | $65 | $39.28 | +249.7% | Nov 16, 2021 |
| Loop Capital Markets | Daniel Adam | $105 | $57 | +464.8% | Sep 20, 2021 |
| Credit Suisse | Benjamin Chaiken | $85 | $59.84 | +357.2% | Sep 15, 2021 |
| Goldman Sachs | Stephen Grambling | $73 | $52.36 | +292.7% | Aug 9, 2021 |
| Jefferies | David Katz | $75 | $48.81 | +303.4% | Jun 16, 2021 |
| Cannonball Research | Vasily Karasyov | $80 | $48.42 | +330.3% | May 7, 2021 |
Track every rating change on DKNG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationDraftKings Inc. operates as a leading digital enterprise specializing in sports entertainment and gaming. The company provides sophisticated multi-channel sports betting and gaming technology solutions to operators across 17 countries, facilitating diverse entertainment experiences. Directly, DraftKings manages its own iGaming services under the DraftKings brand in five U.S. states, and separately operates Golden Nugget Online Gaming, another iGaming offering, in three states. Its Sportsbook platform is accessible for both mobile and physical wagers in 18 U.S.…
Historical context
All DKNG earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| NKE NIKE, Inc. | FY2027 Q1 · Calendar Q4 2026 | +10.0% | -0.7% | Nike’s performance categories grow as resets weigh on FY27 outlook |
| CCL Carnival Corporation & plc | FY2026 Q3 · Calendar Q3 2026 | +5.9% | +13.4% | Carnival posts record Q3 as demand and efficiency offset fuel costs |
| DRI Darden Restaurants, Inc. | FY2027 Q1 · Calendar Q3 2026 | 0.0% | -3.0% | Darden reaffirms FY2027 outlook as brands deliver mixed comp growth |
| AZO AutoZone, Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.6% | +3.3% | AutoZone pairs commercial momentum with an aggressive FY2027 expansion plan |
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the DKNG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-03T00:46:07.058364+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T00:46:07.055564+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.